0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Cytokines > TGF-beta 3 > TG3-H5213

Human Latent TGF-beta 3 / Latent TGFB3 Protein, Tag Free

  • Synonym
    TGFB3,ARVD,TGF-beta3
  • Source
    Human Latent TGF-beta 3 / Latent TGFB3, Tag Free (TG3-H5213) is expressed from human 293 cells (HEK293). It contains AA Ala 301 - Ser 412 (Accession # P10600-1).
    Predicted N-terminus: Ala 301
  • Molecular Characterization
    Online(Ala 301 - Ser 412) P10600-1

    This protein carries no "tag".

    The protein has a calculated MW of 12.7 kDa. The protein migrates as 12 kDa under reducing (R) condition (SDS-PAGE).

  • Endotoxin
    Less than 1.0 EU per μg by the LAL method.
  • Purity

    >95% as determined by SDS-PAGE.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in 50 mM HAC, pH3.2. Normally trehalose is added as protectant before lyophilization.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
SDS-PAGE
Human Latent TGF-beta 3 / Latent  TGFB3, Tag Free (Cat. No. TG3-H5213) SDS-PAGE gel

Human Latent TGF-beta 3 / Latent TGFB3, Tag Free on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 95%.

Bioactivity-ELISA
Human Latent TGF-beta 3 / Latent  TGFB3, Tag FreeHuman Latent TGF-beta 3 / Latent  TGFB3, Tag Free (Cat. No. TG3-H5213) ELISA bioactivity

Immobilized Human Latent TGF-beta 3 / Latent TGFB3, Tag Free (Cat. No. TG3-H5213) at 2 μg/mL (100 μL/well) can bind Biotinylated Human TGF-beta RII, His,Avitag (Cat. No. TG2-H82E4) with a linear range of 1-10 ng/mL (QC tested).

  • Background
    Transforming growth factor beta 3 ( TGFB3) is also known as TGF-β3, is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including regulates embryogenesis and cell differentiation and is required in various processes such as secondary palate development. TGF-beta 3 is similar with TGF-beta 1 and ­-beta 2, act as cellular switches to regulate immune function, cell proliferation, and epithelial­-mesenchymal transition. TGF-beta-3 is released from LAP by integrins: integrin-binding results in distortion of the LAP chain and subsequent release of the active TGF-beta-3. Once activated following release of LAP, TGF-beta-3 acts by binding to TGF-beta receptors (TGFBR1 and TGFBR2), which transduce signal.
  • Clinical and Translational Updates
      
  • Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.

Comments (0)

Order Details

Price(USD) : $290.00

Price(USD) : $1920.00

Price(USD) : $4420.00

Promotion & Exhibitions



Drug Development Status

  • Number of Launched Drugs:0 Details
  • Number of Drugs in Clinical Trials:1 Details
  • Latest Research Phase:Phase 1 Clinical

Datasheet & Documentation

Request for DMF
DMF (Drug Master File)

Contact Us

+1  800-810-0816 (US)
+86 400-682-2521 (AP)

Questions & Comments

This web search service is supported by Google Inc.

totop